Apellis Pharmaceuticals Inc. (NASDAQ:APLS) has a beta value of 1.54 and has seen 1.12 million shares traded in the last trading session. The company, currently
In the last trading session, 1.08 million Apellis Pharmaceuticals Inc. (NASDAQ:APLS) shares changed hands as the company’s beta touched 1.52. With the company’s per share
Apellis Pharmaceuticals Inc. (NASDAQ:APLS) has a beta value of 1.50 and has seen 3.0 million shares traded in the recent trading session. The company, currently
Apellis Pharmaceuticals Inc. (NASDAQ:APLS)’s traded shares stood at 1.08 million during the last session, with the company’s beta value hitting 1.52. At the close of